Circulars

31 March 2023

Safety alerts regarding pharmaceutical products and medical devices

Reference: CIR-2023-00000044

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Safety update of pharmaceutical product Bemiparin

Safety update of pharmaceutical product Omeprazole

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

اضافة تحذير على المنتج الطبي - Bemiparin ---.pdf:

View Document

اضافة تحذير على المنتج الطبي -Omeprazole ==.pdf:

View Document